Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 73

Sort by

Sort Order Select

Journal Articles

Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort

Shouriyo Ghosh, Florian Kuchenbauer, Ryan J Stubbins, Shanee Chung, Sujaatha Narayanan, Thomas J. Nevill, Kevin Song, Judith Anula Rodrigo, Jennifer White, Claudie Roy, Yasser Abou Mourad, Stephen H. Nantel, Donna L. Forrest, Cynthia L. Toze, Kevin A Hay, Maryse Power, David Sanford

Blood (2023) 142 (Supplement 1): 1482.

https://doi.org/10.1182/blood-2023-182466

Published: 2023

Journal Articles

British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib

Shanee Chung, Ashley Kate McEwan, Yasser Abou Mourad, Donna L. Forrest, Kevin Hay, Florian Kuchenbauer, Stephen H. Nantel, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Sujaatha Narayanan

Blood (2023) 142 (Supplement 1): 6972.

https://doi.org/10.1182/blood-2023-190446

Published: 2023

Journal Articles

Real-World Outcomes of Pfts in Screening for Lung Involvement in Chronic Gvhd Post-Allogeneic Stem Cell Transplant: A Retrospective Study of 387 Patients in British Columbia, Canada

Bo Wan, Yasser Abou Mourad, Shanee Chung, Donna L. Forrest, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse Power, Judith Anula Rodrigo, David Sanford, Kevin Song, Ryan J Stubbins, Heather J. Sutherland, Cynthia L. Toze, Jennifer White, Claudie Roy, Kevin A Hay

Blood (2023) 142 (Supplement 1): 3559.

https://doi.org/10.1182/blood-2023-185055

Published: 2023

Journal Articles

Autologous Stem Cell Transplantation for Treatment with Curative Intent in Adult Patients with Acute Lymphoblastic Lymphoma

Jessica L. Bazin, Yasser Abou Mourad, Donna L. Forrest, Kevin Hay, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse Power, Judith A Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J. Stubbins, Heather J. Sutherland, Cynthia L. Toze, Jennifer White, Shanee Chung

Blood (2022) 140 (Supplement 1): 7718–7720.

https://doi.org/10.1182/blood-2022-165411

Published: 2022

Journal Articles

Clinical Outcomes in Fresh Versus Cryopreserved Hematopoietic Stem Cell Products in British Columbia: A Retrospective Study

Blood (2022) 140 (Supplement 1): 7555–7557.

https://doi.org/10.1182/blood-2022-163594

Published: 2022

Journal Articles

Autologous Stem Cell Transplant Outcome in Classic Hodgkin Lymphoma Patients in the Era of Post-Transplant Brentuximab Vedotin Consolidation

Shanee Chung, Jennifer White, Cynthia L. Toze, Heather J. Sutherland, David Sanford, Judith Anula Rodrigo, Thomas J. Nevill, Sujaatha Narayanan, Stephen H. Nantel, Florian Kuchenbauer, Kevin A. Hay, Donna L. Forrest, Yasser Abou Mourad, Kevin Song, Maryse Power

Blood (2021) 138 (Supplement 1): 3935.

https://doi.org/10.1182/blood-2021-154492

Published: 2021

Journal Articles

Outcome of Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL) with Intention for Curative Therapy Incorporating High Dose Chemotherapy and Hematopoietic Stem Cell Transplant (HDC/SCT)

Henry S. Ngu, Stephen Parkin, David W. Scott, Diego Villa, Alina S. Gerrie, Cynthia L. Toze, Maryse Power, Graham W Slack, Joseph M. Connors, Kevin Song, Laurie H. Sehn, Kerry J. Savage

Blood (2021) 138 (Supplement 1): 624.

https://doi.org/10.1182/blood-2021-146352

Published: 2021

Journal Articles

Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)

Rania S. Khelifi, Steven J.T. Huang, BMLSc, Kerry J. Savage, MDMSc, Diego Villa, MDMPH, David W. Scott, MBChB, PhD, Khaled Ramadan, MBBCH, MRCP, FRCPath, Joseph M. Connors, MD, Laurie H. Sehn, MDMPH, Cynthia L Toze, MD FRCPC, Alina S. Gerrie, MD MPH

Blood (2020) 136 (Supplement 1): 33–34.

https://doi.org/10.1182/blood-2020-138887

Published: 2020

Journal Articles

Hodgkin Variant of Richter's Transformation (HvRT) Among Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC), Canada

Kai Zhu, Andrew Jamroz, Bsc, Steven J.T. Huang, BMLSc, Diego Villa, MDMPH, Ciara L. Freeman, MSc, MBBChir, David W. Scott, MBChB, PhD, Graham W. Slack, MD, Laurie H. Sehn, MDMPH, Joseph M. Connors, MD, Cynthia L. Toze, MDFRCPC,MSc, Kerry J. Savage, MDMSc, Alina S. Gerrie, MD MPH

Blood (2020) 136 (Supplement 1): 13–15.

https://doi.org/10.1182/blood-2020-141183

Published: 2020

Journal Articles

Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)

Elysha Vanderveer, MD BSc, Steven J.T. Huang, BMLSc, Helene Bruyere, MD FCCMG, Tanya Gillan, PhD FCCMG, Charles H. Li, MDFRCPC, Khaled Ramadan, MBBCH, MRCP, FRCPath, Diego Villa, MD MPH, David W. Scott, MBChB, PhD, Kerry J Savage, BSc, MD MSc, Joseph M Connors, MD, Laurie H Sehn, MD, Cynthia L Toze, MD FRCPC, Alina S Gerrie, MD MPH

Blood (2019) 134 (Supplement_1): 4300.

https://doi.org/10.1182/blood-2019-125189

Published: 2019

Journal Articles

Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma

Diego Villa, MD MPH, Laurie H Sehn, MD, Kerry J Savage, BSc, MD MSc, Cynthia L Toze, MD FRCPC, Kevin Song, MD, Wendie L den Brok, Ciara L Freeman, MSc, MBBChir, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH

Blood (2019) 134 (Supplement_1): 2814.

https://doi.org/10.1182/blood-2019-124217

Published: 2019

Journal Articles

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Jean Roy, MD, Tony Panzarella, M.Sc., P.Stat, Stephen Couban, MDBSc, Félix Couture, MD FRCPC, Gerald M. Devins, PhD, Mohamed Elemary, MD, Stephen Ronan Foley, MD FRCPC, Genevieve Gallagher, MD, John Kuruvilla, MD, Stephanie J. Lee, MD MPH, John Moore, MDFRACP,FRCPA, Thomas J Nevill, MD, Gizelle Popradi, MD FRCP, Kirk R. Schultz, MD, David Szwajcer, MD FRCPC, Cynthia L Toze, MD FRCPC, Irwin Walker, MBBS, FRCPC

Blood (2019) 134 (Supplement_1): 875.

https://doi.org/10.1182/blood-2019-123275

Published: 2019

Journal Articles

Bendamustine Adversely Affects Stem Cell Mobilization Among Patients with Mantle Cell Lymphoma (MCL): A Comparison of the BR Vs RCHOP Eras in British Columbia (BC), Canada

Hatem Alahwal, MPH, MBBS, Parv Chapani, Diego Villa, MD FRCPC, Yasser Abou Mourad, MD, Maryse Power, MD, Stephen H. Nantel, MD, David Sanford, MD, Gayatri Sreenivasan, BSc, MD, Heather J. Sutherland, MD PhD, Laurie H Sehn, MD MPH, Cynthia L. Toze, MD FRCPC, MSc, Raewyn Broady, MBChB, Kevin Song, MD, Paul Yenson, MD BSc, FRCPC, Alina S. Gerrie, MD MPH

Blood (2018) 132 (Supplement 1): 4556.

https://doi.org/10.1182/blood-2018-99-114371

Published: 2018

Journal Articles

Older Adults with Acute Myeloid Leukemia in Rural Areas Are Less Likely to Receive Azacitidine with Worsened Overall Survival

Ryan J Stubbins, MD MSc, Lauren Lee, MD, Yasser Abou Mourad, MD, Michael J Barnett, BM, Raewyn Broady, MBChB, Donna L. Forrest, MD, Alina S. Gerrie, MD MPH, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD, Sujaatha Narayanan, MBBS, Thomas J Nevill, MD, Maryse Power, MD, Kevin Song, MD, Heather J. Sutherland, MD PhD, Cynthia L Toze, MD, Jennifer White, MD, David Sanford, MD

Blood (2018) 132 (Supplement 1): 3989.

https://doi.org/10.1182/blood-2018-99-111532

Published: 2018

Journal Articles

Unsuccessful Cytogenetics and Outcomes in Acute Leukemia

Lauren Lee, MD, Helene Bruyere, MD, Michael J Barnett, BM, Raewyn Broady, MBChB, Donna L. Forrest, MD, Alina S. Gerrie, MD MPH, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD, Sujaatha Narayanan, MBBS, Maryse Power, MD, David Sanford, MD, Kevin Song, MD, Heather J. Sutherland, MD PhD, Cynthia L Toze, MD, Jennifer White, MD, Yasser Abou Mourad, MD

Blood (2018) 132 (Supplement 1): 2673.

https://doi.org/10.1182/blood-2018-99-110470

Published: 2018

Journal Articles

Characteristics of Patients (pts) Who Relapse and Die of Multiple Myeloma (MM) within One Year Post Frontline Autologous Stem Cell Transplant (ASCT) in the Novel Agent Era: An Ultra-High Risk Population

Hatem Alahwal, MPH, MBBS, Heather J. Sutherland, MD PhD, Shruthi Ganeshappa Kodad, MD, Stephen H. Nantel, MD, Yasser Abou Mourad, MD, Michael J. Barnett, BMBS, Donna L. Forrest, MD, Alina S. Gerrie, MD MPH, Donna E. Hogge, MD PhD, Sujaatha Narayanan, MBBS, MRCP, MRCPath, Thomas J. Nevill, MD, Maryse Power, MD, David Sanford, MD, Cynthia L. Toze, MD FRCPC, MSc, Jennifer White, MD, Raewyn Broady, MBChB, Kevin Song, MD

Blood (2018) 132 (Supplement 1): 3440.

https://doi.org/10.1182/blood-2018-99-111533

Published: 2018

Journal Articles

Outcomes of Intermediate Risk Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared to Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-Score Adjusted Analysis

Wasithep Limvorapitak, MD, Michael J Barnett, BM, Donna Hogge, Donna L Forrest, MD, Thomas J Nevill, MD, Sujaatha Narayanan, MBBS, Maryse Power, MB, Stephen H Nantel, MD, Raewyn Broady, MBChB, FRACP, Kevin W Song, MD, Cynthia L Toze, MD, Yasser Abou Mourad, MD, Heather Sutherland, MD, Alina S Gerrie, MD, Jennifer White, MD, David Sanford, MD

Blood (2017) 130 (Supplement 1): 4544.

https://doi.org/10.1182/blood.V130.Suppl_1.4544.4544

Published: 2017

Journal Articles

Long-Term Outcomes of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Etoposide and Cyclophosphamide

Amir Siddiqui, Donna E. Hogge, MD PhD, Thomas J. Nevill, MD, Stephen H. Nantel, MD FRCPC, Michael J Barnett, BMBS, Raewyn Broady, MBChB, Donna L. Forrest, MD, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Maryse M Power, MD, Kevin W. Song, MD, Cynthia L. Toze, MD MHSc, FRCPC, Yasser Abou Mourad, MD, Heather J. Sutherland, MD PhD, Alina S. Gerrie, MD MPH, FRCPC, David Sanford, MD FRCPC

Blood (2016) 128 (22): 2814.

https://doi.org/10.1182/blood.V128.22.2814.2814

Published: 2016

Journal Articles

Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada

Katie Y. Zhu, BHSc, Kevin W. Song, MD, Joseph M Connors, MD, Tracy Tucker, PhD FCCMG, Graham W. Slack, MD, Yasser Abou Mourad, MD, Michael J Barnett, BMBS, FRCPC, FRCP, FRCPath, Donna L. Forrest, MD FRCPC, Donna E. Hogge, MD PhD, Stephen H. Nantel, MD FRCPC, Sujaatha Narayanan, MBBS, MRCP, FRCPath, Thomas J. Nevill, MD FRCPC, Maryse M Power, MB, MRCPI, FRCPath, David Sanford, MD FRCPC, Cynthia L. Toze, MD MHSc, FRCPC, Heather J. Sutherland, MD PhD FRCPC, Laurie H. Sehn, Raewyn Broady, MBChB, FRACP, Alina S. Gerrie, MD MPH, FRCPC

Blood (2016) 128 (22): 1113.

https://doi.org/10.1182/blood.V128.22.1113.1113

Published: 2016

Journal Articles

Outcome of Patients with Peripheral T-Cell Lymphoma Undergoing Allogeneic Stem Cell in British Columbia

Blood (2016) 128 (22): 5852.

https://doi.org/10.1182/blood.V128.22.5852.5852

Published: 2016

NARROW

Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort

British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib

Real-World Outcomes of Pfts in Screening for Lung Involvement in Chronic Gvhd Post-Allogeneic Stem Cell Transplant: A Retrospective Study of 387 Patients in British Columbia, Canada

Autologous Stem Cell Transplantation for Treatment with Curative Intent in Adult Patients with Acute Lymphoblastic Lymphoma

Clinical Outcomes in Fresh Versus Cryopreserved Hematopoietic Stem Cell Products in British Columbia: A Retrospective Study

Autologous Stem Cell Transplant Outcome in Classic Hodgkin Lymphoma Patients in the Era of Post-Transplant Brentuximab Vedotin Consolidation

Outcome of Relapsed and Refractory Peripheral T-Cell Lymphoma (PTCL) with Intention for Curative Therapy Incorporating High Dose Chemotherapy and Hematopoietic Stem Cell Transplant (HDC/SCT)

Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)

Hodgkin Variant of Richter's Transformation (HvRT) Among Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC), Canada

Oral Fludarabine and Intravenous Rituximab (FR) for Chronic Lymphocytic Leukemia (CLL): Long Term Outcomes and Secondary Malignancies in 673 Patients Treated in British Columbia (BC)

Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma

Less Chronic Graft-Versus-Host Disease, Immunosuppressive Therapy and Better Survival after Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplant Recipients: Longer Follow-up of a Multicentre Cell Therapy Transplant Canada Randomized Trial

Bendamustine Adversely Affects Stem Cell Mobilization Among Patients with Mantle Cell Lymphoma (MCL): A Comparison of the BR Vs RCHOP Eras in British Columbia (BC), Canada

Older Adults with Acute Myeloid Leukemia in Rural Areas Are Less Likely to Receive Azacitidine with Worsened Overall Survival

Unsuccessful Cytogenetics and Outcomes in Acute Leukemia

Characteristics of Patients (pts) Who Relapse and Die of Multiple Myeloma (MM) within One Year Post Frontline Autologous Stem Cell Transplant (ASCT) in the Novel Agent Era: An Ultra-High Risk Population

Outcomes of Intermediate Risk Acute Myeloid Leukemia in First Remission Undergoing Autologous Stem Cell Transplantation Compared to Allogeneic Stem Cell Transplantation and Chemotherapy Consolidation: A Retrospective, Propensity-Score Adjusted Analysis

Long-Term Outcomes of Patients with Acute Myeloid Leukemia Treated with Salvage High-Dose Etoposide and Cyclophosphamide

Population-Based Survival Outcomes in Adult Patients with Burkitt Lymphoma (BL) Treated with Cyclophosphamide, Vincristine, Doxorubicin, High-Dose Methotrexate (CODOX-M)/Ifosfamide, Etoposide and High-Dose Cytarabine (IVAC) Plus or Minus Rituximab (R) in British Columbia (BC), Canada

Outcome of Patients with Peripheral T-Cell Lymphoma Undergoing Allogeneic Stem Cell in British Columbia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only